Clinical Trial Update: Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing imatinib alone to imatinib plus pegylated interferon in Philadelphia-positive chronic myeloid leukemia patients with complete cytogeneti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: Sheba Medical Center | Conditions: Leukemia, Myeloid, Philadelphia-Positive | Phase 3 | Status: UNKNOWN